Literature DB >> 6290803

A reappraisal of limited-stage undifferentiated carcinoma of the lung. Does stage I small cell undifferentiated carcinoma exist?

I L Kron, P K Harman, S E Mills, A N Walker, P H Cooper, G R Minor, S P Nolan.   

Abstract

Patients with small cell undifferentiated carcinoma of the lung (SCUC) have a poor prognosis. Surgical excision is avoided if the diagnosis can be made with small biopsy specimens or cytologic preparations. We reviewed 323 consecutive patients with pulmonary neoplasms diagnosed as SCUC, oat cel carcinoma, and undifferentiated or poorly differentiated carcinoma. At the time of diagnosis, only 18 patients had neoplasms classified as clinical Stage I, and only one of these had SCUC after histologic review. Fifteen patients had atypical carcinoid, a tumor with features intermediate between ordinary bronchial carcinoid and SCUC. In two instances, there was insufficient tissue for definitive diagnosis. Cumulative survival of the 15 patients with Stage I atypical carcinoid tumor was 80% at 1 year and 60% at most recent follow-up (mean follow-up 20 months). Mean survival for the 305 remaining patients was 7.9 months. Atypical carcinoid may be misdiagnosed as SCUC or poorly differentiated carcinoma, particularly with limited tissue samples or cytologic preparations. Stage I SCUC exists but is exceedingly rare. Many examples of purported Stage I SCUC probably represent atypical carcinoid. Because atypical carcinoid has a far better prognosis than SCUC, precise diagnosis is important and surgical resection should be considered.

Entities:  

Mesh:

Year:  1982        PMID: 6290803

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  5 in total

Review 1.  Neuroendocrine differentiation in lung tumours.

Authors:  M N Sheppard
Journal:  Thorax       Date:  1991-11       Impact factor: 9.139

Review 2.  Is there a role for surgery in small-cell lung cancer?

Authors:  J D Urschel; J G Antkowiak; H Takita
Journal:  J R Soc Med       Date:  1997-07       Impact factor: 5.344

3.  The staging of lung cancer.

Authors:  S Spiro; P Goldstraw
Journal:  Thorax       Date:  1984-06       Impact factor: 9.139

Review 4.  Lung cancer--current concepts and controversies.

Authors:  S B Pett; J A Wernly; B F Akl
Journal:  West J Med       Date:  1986-07

5.  Fifteen-year follow-up of all patients in a study of post-operative chemotherapy for bronchial carcinoma.

Authors:  D J Girling; H Stott; R J Stephens; W Fox
Journal:  Br J Cancer       Date:  1985-12       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.